Sundar Selvaraj/NBDF LinkedIn
Sep 26, 2025, 10:44
Sundar Selvaraj – A Scientist Advancing Hemophilia A Research While Living with Severe FXIII Deficiency and VWD 2M
National Bleeding Disorders Foundation (NBDF) shared on LinkedIn:
”Researcher. Advocate. Dad.
Sundar Selvaraj brings a unique dual perspective to the LEE Research Advisory Council, as a scientist studying hemophilia A and as someone living with both severe factor XIII deficiency and type 2M von Willebrand disease.
Based in Michigan, he’s committed to advancing biomedical research while ensuring patient voices stay at the center.
Learn more about Sundar.”
More winner stories featured in Hemostasis Today.
-
May 24, 2026, 16:12William Wallace: Normal B12 Levels May Still Cause Brain Damage and Cognitive Decline
-
May 24, 2026, 15:54Marc Carrier: Ottawa Race Weekend Raised Over 7,000 USD for Thrombosis Canada
-
May 24, 2026, 15:44Janak Sadhu: Building a Stroke-Free Mehsana Through Community Awareness and Healthcare Collaboration
-
May 24, 2026, 15:33Mohammed Zubair: AI-Driven Innovation in Stroke Diagnosis and Medical Imaging
-
May 24, 2026, 14:26Salome Mekhuzla: World Health Assembly Adopts Historic Global Resolution for Hemophilia and Bleeding Disorders
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View